26.70 USD
▼-1.82-0.52%
2026-08-03
市值
$92.80M
市盈率
—
EPS
-20.19
股息率
—
52 周区间
16.50 – 37.50
成交量
132.73K
Beta
3.13
目标价
57.71
52W 低 16.5052W 高 37.50
价格走势
公司简介
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestati...